ANXA1 and Parkinson disease: To test if the loss of Anxa1+ neurons is merely an early biomarker of disease, or could actually be the cause of early symptoms in PD, we selectively silenced synaptic release of Anxa1+ DANs with an AAV expressing tetanus toxin31 (AAV-FLEX-TeLC-EYFP; Figure 6).